Showing results (1-10 of 325) with videos related to

Sort By:
Pageof 33
Current Opinion in Pulmonary Medicine|July 1, 1997
Current status on new anticoagulant and antithrombotic drugs and devicesJ M Walenga, J Fareed
Clinics in Laboratory Medicine|December 1, 1994
Automation and quality control in the coagulation laboratoryJ M Walenga, J Fareed
Seminars in Thrombosis and Hemostasis|April 1, 1989
Antithrombotic drugs in pelvic surgeryJ Fareed, J M Walenga, U Cornelli
Thrombosis Research. Supplement|January 1, 1991
Laboratory monitoring of the clinical effects of low molecular weight heparinsJ M Walenga, D Hoppensteadt, J Fareed
Drugs & Aging|September 1, 1992
Low molecular weight heparins. An objective overviewD Hoppensteadt, J M Walenga, J Fareed
Thrombosis Research|November 1, 1990
Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate and heparinD Hoppensteadt, J M Walenga, J Fareed
Seminars in Thrombosis and Hemostasis|October 1, 1984
Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide AJ Amiral, J M Walenga, J Fareed
Seminars in Thrombosis and Hemostasis|January 1, 1991
Non-heparin glycosaminoglycan-derived drugs: a biochemical and pharmacologic perspectiveJ M Walenga, D Hoppensteadt, J Fareed
Seminars in Thrombosis and Hemostasis|October 1, 1983
Newer avenues in the monitoring of antithrombotic therapy: the role of automationJ M Walenga, J Fareed, H L Messmore
Seminars in Thrombosis and Hemostasis|April 1, 1985
Validity of serine protease inhibition tests in the evaluation and monitoring of the effect of heparin and its fractionsD A Hoppensteadt, J M Walenga, J Fareed
Pageof 33